BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, April 8, 2026
Home » Newsletters » BioWorld

BioWorld

March 9, 2015

View Archived Issues

BioWorld stock report for public biotechnology companies

Read More

BioWorld Stock Index 2015

Read More

Nasdaq Stock Index 2015

Read More

Money raised by biotech Jan. 1 - March 5, 2015

Read More

Money raised by biotech in 2015 vs. 2014

Read More

Milestone payments from corporate partners: February 2015

Read More

Venture capital & other investments in private biotechnology companies: February 2015

Read More

2015 top financings of private companies

Read More

Other financings of public biotechnology companies: February 2015

Read More

2015 top private financings of public companies

Read More

Secondary trading environment critical for small businesses

Emerging companies are considered to be the drivers of U.S. economic activity, innovation and job creation. Their ability to survive and prosper depends on ready access to capital, particularly in the private markets. The SEC Advisory Committee on Small and Emerging Companies met to discuss ways in which the secondary trading environment for the securities of small businesses can be improved. It is an issue that needs to be solved quickly in view of a projected increase in those securities. Read More

Week in review

Read More

Word on the street

Read More

Week in Washington

Read More

Biotech money raised by month in 2015

Read More

Public financing of biotechnology companies: Commenced trading in February 2015

Read More

Public financing of biotechnology companies: Filed and pending IPOs

Read More

Developing targeted therapies for head and neck cancers

The American Society of Clinical Oncology (ASCO) estimates that cancers of the head and neck, a diverse group of tumors that arise in the mouth, nose, throat and larynx, account for about 3 percent of all malignancies in the U.S. Most are squamous cell carcinomas that begin in the flat, squamous cells that make up the epithelium of the head and neck. Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 7, 2026.
  • Hengrui discovers new Nav1.8 blockers

    BioWorld Science
    Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
  • Cancer and blood cells

    Hematopoietic stem cell research points to leukemia’s early roots

    BioWorld Science
    Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for April 7, 2026
  • 3D illustration of antibodies

    Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis

    BioWorld Science
    Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing